12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. Lexaria Bioscience (LEXX) led the gainers with a 19.0% increase, while Ainos (AIMD) saw the largest decline among the losers, dropping 11.0%. Other notable movers included Personalis (PSNL), Atreca (BCEL), Moleculin Biotech (MBRX), and Exagen (XGN) with gains, and Altamira Therapeutics (CYTO), SILO Pharma (SILO), Eiger BioPharmaceuticals (EIGR), UpHealth (UPH), and TRACON Pharma (TCON) with losses.
November 21, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ainos's stock decreased by 11.0% in after-market trading, with a market cap of $11.5 million.
The substantial after-market drop for AIMD could indicate bearish sentiment, potentially leading to a short-term downtrend in its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Altamira Therapeutics's stock fell by 8.43% to $0.34, with a market cap of $2.6 million.
The decline in Altamira Therapeutics's stock price during after-market hours could suggest a short-term negative impact.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Eiger BioPharmaceuticals's stock declined by 6.18% to $0.31, with a market cap of $13.8 million.
Eiger BioPharmaceuticals's stock price decrease in after-market trading may lead to a short-term negative impact on its stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
SILO Pharma's stock declined by 7.07% to $1.71, with a market cap of $5.3 million.
The after-market drop for SILO Pharma may indicate a short-term bearish sentiment among investors.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
TRACON Pharma's shares fell by 5.07% to $0.21, with a market cap of $6.4 million.
The after-market drop in TRACON Pharma's stock price could indicate a short-term negative impact.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
UpHealth's shares declined by 5.28% to $0.75, with a market cap of $12.8 million.
The after-market decline for UpHealth may suggest a short-term downward trend in its stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Atreca's stock went up by 9.47% to $0.23, with a market cap of $9.1 million.
The after-market gain for BCEL may lead to a short-term positive trend in its stock price, given the investor interest reflected in the rise.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Lexaria Bioscience's stock rose by 19.0% in after-market trading, with a market cap of $14.6 million.
The significant after-market gain for LEXX suggests positive investor sentiment which could lead to a short-term price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Moleculin Biotech's shares rose by 9.15% to $0.57, with a market cap of $16.9 million.
Moleculin Biotech's after-market increase could suggest a short-term bullish trend for its stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Personalis's stock increased by 11.6% to $1.63, with a market cap of $79.8 million.
Personalis's after-market rise could attract investor attention, potentially leading to a short-term positive impact on its stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Exagen's shares increased by 6.44% to $1.65, with a market cap of $27.9 million.
Exagen's stock price appreciation in after-market trading may lead to a short-term positive impact on its stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80